Structure-Function Analysis of the HrpB2-HrcU Interaction in the Xanthomonas citri Type III Secretion System by Cappelletti, Paola A. et al.
Structure-Function Analysis of the HrpB2-HrcU
Interaction in the Xanthomonas citri Type III Secretion
System
Paola A. Cappelletti
1, Rafael Freitas dos Santos
1, Alexandre M. do Amaral
2,3, Rafael Augusto Homem
3,
Thaı ´s dos Santos Souza
1, Marcos A. Machado
3, Chuck S. Farah
1*
1Departamento de Bioquı ´mica, Instituto de Quı ´mica, Universidade de Sa ˜o Paulo, Sa ˜o Paulo, Sa ˜o Paulo, Brazil, 2EMBRAPA Recursos Gene ´ticos e Biotecnologia, Brası ´lia,
Distrito Federal, Brazil, 3Centro APTA Citros ‘‘Sylvio Moreira’’/IAC, Cordeiropolis, Sa ˜o Paulo, Brazil
Abstract
Bacterial type III secretion systems deliver protein virulence factors to host cells. Here we characterize the interaction
between HrpB2, a small protein secreted by the Xanthomonas citri subsp. citri type III secretion system, and the cytosolic
domain of the inner membrane protein HrcU, a paralog of the flagellar protein FlhB. We show that a recombinant fragment
corresponding to the C-terminal cytosolic domain of HrcU produced in E. coli suffers cleavage within a conserved Asn264-
Pro265-Thr266-His267 (NPTH) sequence. A recombinant HrcU cytosolic domain with N264A, P265A, T266A mutations at the
cleavage site (HrcUAAAH) was not cleaved and interacted with HrpB2. Furthermore, a polypeptide corresponding to the
sequence following the NPTH cleavage site also interacted with HrpB2 indicating that the site for interaction is located after
the NPTH site. Non-polar deletion mutants of the hrcU and hrpB2 genes resulted in a total loss of pathogenicity in
susceptible citrus plants and disease symptoms could be recovered by expression of HrpB2 and HrcU from
extrachromossomal plasmids. Complementation of the DhrcU mutant with HrcUAAAH produced canker lesions similar to
those observed when complemented with wild-type HrcU. HrpB2 secretion however, was significantly reduced in the DhrcU
mutant complemented with HrcUAAAH, suggesting that an intact and cleavable NPTH site in HrcU is necessary for total
functionally of T3SS in X. citri subsp. citri. Complementation of the DhrpB2 X. citri subsp. citri strain with a series of hrpB2
gene mutants revealed that the highly conserved HrpB2 C-terminus is essential for T3SS-dependent development of citrus
canker symptoms in planta.
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Introduction
Many Gram-negative bacterial pathogens produce proteina-
ceous pathogenic factors that are secreted and injected into the
host cell via the type III secretion system (T3SS) during the
infective process [1,2,3]. A great deal of focus has been aimed at
understanding the T3SS of phytopathogenic Xanthomonas species
that infect a wide variety of plant hosts, many of which are of great
economic importance [1,4,5,6,7,8,9,10,11,12,13,14,15]. The phy-
topathogen Xanthomonas citri subsp. citri (Xanthomonas axonopodis pv
citri strain 306; Xac) is the causal agent of citrus canker, a disease
that threatens citrus crops world-wide [16]. The Xac hrp locus (hrp:
‘‘hypersensitive response and pathogenicity’’) encompasses a group
of 25 genes that code for a T3SS. Some products encoded by these
genes are conserved in all T3SS, including core flagellar secretory
components, while others are proteins of unknown function but
whose homologs are essential for T3SS function in other
Xanthomonas species [5,7,17].
The Xac T3SS is required for the development of disease
symptoms in susceptible citrus plants as well as for the
hypersensitive response (HR) in resistant plants [17,18]. Deletions
in the hrpB and hrpD operons and deletions of the hrpF gene in Xac
failed to produce canker in citrus plants or hypersensitive response
(HR) in cotton [17]. Furthermore, a specific T3SS substrate, PthA
(a member of the AvrBs3 family), has been shown to contribute
significantly to T3SS-dependent development of disease symptoms
by Xac in citrus and the introduction of the pthA gene into strains of
X. phaseoli and X. campestris pv. malvacearum (neither pathogenic in
citrus) resulted in the elicitation of HR in their respective hosts,
bean and cotton [18]. A PthA homolog coded by the hssB3.0 gene
was found to be required for virulence of Xac KC21 on Citrus
grandis cultivars [19]. Other possible T3SS-related factors have
been identified in the Xac genome by bioinformatics analysis [7]
but have not been studied at the genetic or protein level.
We have previously identified protein-protein interactions
involving components, substrates and regulators of the T3SS of
Xac strain 306 [5] whose genome has been sequenced [7]. One of
the interactions identified was that involving HrpB2 and HrcU.
HrpB2 is a small protein found associated with the T3SS of only a
few phytopathogenic bacteria (Xanthomonas spp., Ralstonia solana-
cearum, Acidovorax avenae) and of Burkholderia spp that can infect
animals and plants. In Xanthomonas campestris pv. vesicatoria (Xcv),
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virulence protein by the T3SS [20] and has been shown to interact
with HpaC, a protein required for the efficient secretion of other
effectors proteins [21]. These observations have led to the
suggestion that HrpB2 may play a role in controlling the hierarchy
of a stepwise secretion process [20,21].
HrcU homologs are found in all known T3SSs and flagellar
systems and are made up of an N-terminal domain containing
several transmembrane helices and a cytoplasmic C-terminal
domain. In Xanthomonas campestris pv. glycines 8ra, the HrcU
homolog is not required for HR induction on non-host plants,
pepper and tomato, or for the multiplication of bacteria in the host
plant, but was required for the pathogenic symptoms on soybean
[22]. On the other hand, insertion mutagenesis in the Xcv hrpC
operon, which codes for both HrcU and HrcV, resulted in
nonpathogenic mutants that exhibited significantly reduced
growth in pepper leaves and lost the ability to induce HR in
resistant host plants and in non-hosts [23].
HrcU is a paralog of the flagellar protein FlhB. The 173-residue
C-terminal domain of FlhB from Salmonella is specifically cleaved
between Asn-269 and Pro-270 within a NPTH motif [24] via an
autocatalytic process [25]. This NPTH motif is conserved in all
FlhB homologs, including those found in T3SS of animal and
plant pathogens and a similar cleavage has been observed in the
homolog YscU from the T3SS of Yersinia pseudotuberculosis [26]. In
flagellar systems, mutations that abolish cleavage in FlhB also
abolish the secretion of flagellin and other late export extracellular
components but not early export proteins such as FlgD [27].
Cleavage of YscU does not however seem to be essential for the
secretion of virulence factors by the Yersinia T3SS [26] and thus
appears to discriminate between translocator and effector proteins
[28]. Substitutions of N263 abolish autocleavage of YscU while
P264 and H266 showed partial cleavage [29]. Structural studies of
YcsU [29] and its homologs EscU from enteropatogenic E. coli,
SpaS from Salmonella typhimurium [30] and Spa40 from Shigella
flexneri [31] reported similar structural and functional data.
In this report, we have characterized the interaction between
HrpB2 and the C-terminal domain of HrcU of Xac using purified
recombinant proteins. We show that when expressed in E. coli,
HrcUXAC suffers a cleavage within the NPTH motif in a manner
similar to that observed for the HrcU homologs FlhB and
YscU and that the HrpB2XAC binding site on HrcUXAC
corresponds to the region C-terminal to the cleavage site.
Deletion mutations in the hrcU and hrpB2 genes (DhrcU and
DhrpB2) resulted in a total loss of virulence in planta and
pathogenicity could be regained by the expression of HrcUXAC
and HrpB2XAC from extrachromosomal plasmids. Furthermore,
citrus canker symptoms could be observed in infections of the
DhrcU mutant expressing a HrcUXAC variant in which the NPTH
site has was abolished. We also show that HrpB2XAC is secreted
in a manner that depends on HrcUXAC but is only partly
dependent on HrcUXAC cleavage. Expression of HrpB2XAC
variants in a DhrpB2 background showed that the last seven
amino acids are essential for HrpB2XAC function in the
development of canker disease symptoms.
Results
Expression of the cytosolic domain of HrcUXAC
(HrcUXAC_207–357)i nE. coli produces a 7 kDa polypeptide
The C-terminal domain of HrcU corresponding to residues
207–357 (HrcUXAC_207–357, sequence shown in Fig. 1A) was
expressed in E. coli BL21(DE3) cells. The expression of the
recombinant protein was expected to produce a 158 residue,
17 kDa polypeptide. However, SDS-PAGE analysis failed to
detect a 17 kDa fragment but instead a 7 kDa fragment ap-
peared in Coomassie-stained gels after induction with IPTG (data
not shown). This fragment was subsequently purified (Fig. 1B,
lane 1). This result was obtained after expression in a variety of
different E. coli strains including BL21(DE3), BL21(DE3)RP,
BL21(DE3)RIL, BL21(DE3)pLysS, BL21(DE3)CY, BL21(DE3)SI
and BL21(DE3)Star (data not shown).
Figure 1. Expression of HrcUXAC C-terminal fragments. A) Primary sequence of the C-terminal domain (residues 207-357) of HrcUXAC. Residues
207-264 are in italic and residues 277-357 are shown in bold. The underlined sequence was shown to interact with HrpB2XAC in yeast two-hybrid
assays [5]. In HrcUXAC_207-264 and HrcUXAC_207-357(AAAH), residues Q207 and H208 were replaced with Met and Asp residues respectively. The highly
conserved NPTH sequence is double-underlined and the cleavage site between N264 and P265 is indicated with an asterisk. The two tryptophan
(W209 and W340) residues are indicated with a dot above their letter symbols. B) Coomassie-stained SDS-PAGE of purified recombinant HrcU
fragments. Purified HrcUXAC_208-264 (lane 1), HrcUXAC_207-357AAAH (lane 2) and HrcUXAC_His277-357 (lane 3). Molecular mass markers (M) are shown on the
left with masses in kDa. C) Western blots of purified HrcUXAC fragments (lanes 3, 6, 9) and of E. coli cell lysates before (lanes 2, 5, 8) and after (lanes 1,
4, 7) expression using the polyclonal antiserum raised against HrcUXAC_207-357AAAH. HrcUXAC_207-357 (lanes 1-3), HrcUXAC_207-357AAAH (lanes 4-6),
HrcUXAC_His277-357 (lanes 7-9).
doi:10.1371/journal.pone.0017614.g001
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production of a full-length 17 kDa polypeptide
HrcU orthologs and paralogs all possess a conserved Asn-Pro-
Thr-His (NPTH) sequence (residues 264–267 in HrcUXAC,
Fig. 1A) which has been shown to be a site of auto-cleavage in
the flagellar protein FlhB [24,25]. To test the hypothesis that a
similar cleavage was occurring in HrcUXAC_207–357, we mutated
residues 264–266 to alanine and expressed the polypeptide in E.
coli. As shown in Figure 1B (lane 2), expression and purification of
HrcUXAC_207–357(AAAH) produced a protein of the expected size
(17 kDa).
To test whether the 7 kDa fragment was in fact derived from
HrcUXAC_207–357 we used purified HrcUXAC_207–357(AAAH) to
obtain polyclonal antiserum against the HrcUXAC C-terminal
domain. Western blot assays against lysates of E. coli cultures
obtained before and after IPTG-induced expression of
HrcUXAC_207–357 and HrcUXAC_207–357(AAAH) showed that the
antibody recognizes the 17 kDa HrcUXAC_207–357(AAAH) fragment
(Fig. 1C, lanes 4 and 5) as well as the 7 kDa fragment (Fig. 1C,
lanes 1 and 2). The antibody also recognized the purified 7 kDa
fragment (Fig. 1C, lane 3). These results indicate that the purified
7 kDa fragment obtained after HrcU207–357 expression is in fact
derived from HrcUXAC.
N-terminal sequencing by Edman degradation of the 7 kDa
fragment was consistent with the N-terminus beginning at position
207 (XXXLFIRDKR), indicating that the initiation Met residue
was indeed retained. The mass of the purified 7 kDa fragment
determined by MALDI-ToF analysis was very close to the mass
expected from the N-terminal fragment (6911 Da with retention of
the initiation methionine) produced from cleavage between
residues Ans264 and Pro265 of the NPTH sequence within
HrcUXAC_207–357. The above results thus allow us to designate the
name HrcUXAC_207–264 to the 7 kDa polypeptide that was
detected and purified after expression of HrcU207–357.
Cleavage of HrcUXAC_207–357 between residues Asn264 and
Pro265 would be expected to produce two fragments, one N-
terminal fragment beginning at residue 207 and ending at residue
264 (6911 Da) and one C-terminal fragment corresponding to
residues 265–357 (9931 Da). As mentioned above, only a 7 kDa
fragment could be observed to be induced in Coomassie-stained
gels (data not shown). While no 10 kDa fragment was observed to
be induced in Coomassie-stained gels, a faint band could be
observed above the 7 kDa band in the Western blot of E. coli
lysates after induction of HrcU207–357 expression with IPTG
(Fig. 1C, lane 1). Therefore, the evidence so far is consistent with
the cleavage at residue 264 possibly followed by a degradation of a
significant fraction of the 10 kDa fragment in E. coli.
Interactions between HrpB2XAC and fragments derived
from the cytosolic C-terminal domain of HrcUXAC
We have previously shown that HrpB2XAC interacts with
fragments derived from the C-terminal domain of HrcUXAC in
yeast two-hybrid assays [5]. In that study, the smallest HrcUXAC
fragment observed to interact corresponded to residues 256 to 357
(underlined sequence in Fig. 1A). It was therefore not clear
whether HrcUXAC sequences before or after the conserved NPTH
site (or both) were necessary for interaction with HrpB2. We
therefore expressed and purified recombinant HrpB2XAC to
perform in vitro interaction assays with HrcUXAC_207–264 and
HrcUXAC_207–357(AAAH). We also expressed and purified an
HrcUXAC fragment corresponding to residues 277–357 with an
N-terminal His-tag fusion (HrcUXAC_His277–357) (Figure 1B, lane
3). This fragment is recognized by polyclonal anti-HrcUXAC
antibodies both in E. coli lysates and after purification (Figure 1C,
lanes 7, 8 and 9) and its estimated mass determined by MALDI-
ToF spectrometry corresponds well with the expected mass of a
fragment in which the initiation methionine has been retained
(data not shown).
Figure 2A shows the results of Far-Western blot analysis of
the interaction between HrpB2XAC and HrcUXAC_207–357(AAAH)
using polyclonal antibodies raised against HrpB2XAC.
HrpB2XAC bound to immobilized HrcUXAC_207–357(AAAH) (lane
2) but not to an immobilized recombinant C-terminal chicken a-
tropomyosin fragment used as a negative control (lane 3).
Similar experiments using immobilized HrcUXAC_207–264 failed
to detect an interaction (data not shown). Figure 2B shows
that Far-Western assays using immobilized cell lysates obtained
before (lane 2) and after induction (lane 1) of HrpB2XAC
expression as well as purified HrpB2XAC (lane 3). After incu-
bation of the membranes with HrcUXAC_207–357(AAAH),b o u n d
HrcUXAC_207–357(AAAH) could be detected with polyclonal anti-
HrcUXAC antibodies. Again, no interactions could be detected
in similar experiments in which membranes were incubated with
HrcUXAC_207-264 (data not shown).
HrcUXAC_His277–357 corresponds to a fragment that begins
10 residues after the conserved NPTH site. Binding of
HrcUXAC_His277–357 to HrpB2XAC was demonstrated in Far-
Western experiments using E. coli lysates obtained after induction
of expression of HrpB2XAC as well as purified HrpB2XAC.T h e s e
samples were submitted to SDS-PAGE, transferred to nitrocel-
lulose membranes, overlayed with HrcUXAC_His277–357 and
bound HrcUXAC_His277–357 was detected using anti-HrcUXAC
antibodies (Fig. 2C). This interaction was further demonstrated
by immobilizing HrcUXAC_His277–357 on a Ni
2+-chelating resin
and testing whether it could retain HrpB2XAC (Fig. 2D and 2E).
While purified HrpB2XAC did not interact with the Ni
2+-
chelating resin on its own (Fig. 2D, lane 3), it was retained by
HrcUXAC_His277–357 bound to the column (Fig. 2D, lane 4 and
Fig.2E,lane2).SinceHrpB2XAC(14 kDa)andHrcUXAC_His277–357
(10 kDa) have similar mobility in SDS-PAGE, we detected
the individual components of the complex using HrcUXAC-
specific and HrpB2XAC-specific antisera (Fig. 2E, lanes 1 and 2
respectively).
The specific interaction between HrpB2XAC and the region C-
terminal to the HrcUXAC NPTH site was further demonstrated in
fluorescence perturbation assays. The HrpB2XAC protein does not
possess any tryptophan residues. On the other hand, the C-
terminal cytosolic domain of HrcUXAC has two tryptophans, one
at position 209, before the NPTH site, and the other at position
340, after the NPTH site (Fig. 1A). We therefore used the intrinsic
fluorescence of purified HrcUXAC_207–357(AAAH), HrcUXAC_207–264
and HrcUXAC_His277–357 as probes to detect interactions with HrpB2.
Figure 3 shows that the fluorescence of HrcUXAC_207–357(AAAH)
and HrcUXAC_His277–357 is perturbed by the addition of HrpB2XAC
(Fig. 3B and 3C) while the fluorescence of HrcUXAC_207–264 remains
unchanged (Fig. 3A). The addition of HrpB2 caused slight blue-
shifts in the emission spectra of both HrcUXAC_207–357(AAAH)
and HrcUXAC_His277–357 as well as a small increase in intensity.
These results confirm that the site of HrpB2XAC interaction on
HrcUXAC corresponds to the sequence C-terminal to the NPTH
cleavage site.
The NPTH cleavage site is not required for the
development of canker symptoms
To study the contribution of HrcUXAC and its NPTH site to Xac
pathogenicity we employed an allelic exchange protocol to the
produce the DhrcU Xac strain containing in-frame deletions of hrcU
HrpB2 and HrcU Structure - Function Analysis
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the hrcU open reading frame plus 1 kb upstream sequences that
contain the promoter region (pUFR047_hrcU; Table 2). Further-
more, we introduced mutations in this plasmid that change the
NPTH site to AAAH (pUFR047_hrcUAAAH).
Figure 4A shows the results of inoculation of sweet orange leaf
tissue with the Xac wild-type, DhrcU, DhrcU+pUFR047_hrcU and
DhrcU+pUFR047_hrcUAAAH strains 15 days after infection. While
infection with the wild-type strain showed clear disease symptoms
including water-soaking, hyperplasy and necrosis, the DhrcU strain
failed to produce any disease symptoms in the susceptible citrus
host. This result is consistent with the absolute requirement for
HrcU homologs for the functioning of all T3SS systems [22,32].
The phenotype of the DhrcU strain could be reverted by the
expression of wild-type HrcU coded by the pUFR047_hrcU
plasmid or by expression of the HrcUXAC_AAAH coded by the
pUFR047_hrcUAAAH plasmid (Fig. 4A). In both cases, canker
symptoms were less severe than those observed using the wild-type
strain. It is not clear why the reversion of disease symptoms was
attenuated in these experiments. We note that the native upstream
promoter regions contained within these plasmids contain PIP
(plant-inducible promoter) boxes [7] that have been shown to be
recognized by the HrpX transcription factor that controls hrp
expression in Xcv [33,34,35].
The HrpB2XAC C-terminal region is required to elicit citrus
canker symptoms
To study the contribution of HrpB2XAC to Xac pathogenicity,
the allelic exchange protocol was used to produce the
DhrpB2 strain with an in-frame deletion of hrpB2 codons 10-
119 (Table 1). We also produced plasmid pUFR047_hrpB2
(Table 2) which codes for the wild-type HrpB2XAC protein plus a
1 kb upstream region that includes the hrpB1 gene between the
promoter and hrpB2. Figure 4B shows that the DhrpB2 strain was
unable to elicit disease symptoms and that the virulence of the
mutant strain was fully restored by transformation with
pUFR047_hrpB2.
Multiple sequence alignment analysis of HrpB2 proteins from
Xanthomonas, Burkholderia, Acidovorax and Ralstonia species (Figure 5)
indicates that there are two regions of sequence conservation in an
otherwise variable protein family: i) a five residue motif which we
name FQALM that corresponds to positions 35–39 of HrpB2XAC
and ii) the last six amino acids of the protein (HrpB2XAC residues
125–130) which we name the TLMKNQ motif (in Xac the
methionine residue is substituted with a valine).
In order to determine whether either or both of these motifs is
important for HrpB2XAC function in the elicitation of citrus canker
symptoms, we expressed HrpB2XAC fragments or full-length
Figure 2. Interaction of HrpB2XAC with HrcUXAC_207-357AAAH and with HrcUXAC_His277-357.A ) Far-Western blot assays demonstrating the
HrpB2XAC interaction with immobilized HrcUXAC_207-357AAAH. The following purified proteins were separated by SDS-PAGE and transferred to a
nitrocellulose membrane: Lane 1: HrpB2XAC. Lanes 2 and 4: HrcUXAC_207-357AAAH. Lane 3: chicken muscle tropomyosin fragment Tm143-284 [60].
Nitrocellulose strips corresponding to lanes 2 and 3 were incubated with HrpB2 followed by washing to remove unbound proteins. Nitrocellulose
strips corresponding to lanes 1 to 4 were then incubated with polyclonal antiserum raised against HrpB2XAC. The strips were rejoined and revealed
using anti-mouse IgG conjugated with horseradish peroxidase. B) Far-Western Blot assays demonstrating the HrcUXAC_207-357AAAH interaction with
immobilized HrpB2XAC. The following samples were separated by SDS-PAGE and transferred to a nitrocellulose membrane: Lysates of E. coli cells after
(lane 1) and before (lane 2) expression of HrpB2XAC and purified HrpB2XAC (lane 3). The nitrocelulose membrane was incubated with HrcUXAC_207-357AAAH
following by incubation with polyclonal antiserum raised against HrcUXAC_207-357AAAH and revealed using protein A conjugated with horseradish
peroxidase. C) Far-Western Blot assays demonstrating the HrpB2XAC interaction with immobilized HrcUXAC_His277-357. The following samples were
separated by SDS-PAGE and transferred to a nitrocellulose membrane: Lysates of E. coli cells after (lane 1) and before (lane 2) expression of
HrcUXAC_His277-357 and purified HrcUXAC_His277-357 (lane 3). The nitrocellulose membrane was incubated with HrpB2 following by incubation with
polyclonal antiserum raised against HrpB2XAC and revealed as described in part A. D) Pull-down assay demonstrating the interaction of HrpB2XAC with
HrcUXAC_His277-357 immobilized on Ni
2+-chelating resin. HrcUXAC_His277-357 (lane 2), HrpB2XAC (lane 3), a HrpB2XAC plus HrcUXAC_His277-357 mixture (lane 4)
and a mixture of HrcUXAC_His277-357 with an E. coli BL21(DE3) cell lysate (lane 5) were applied to a Ni
2+-chelating resin, washed with buffer containing 25
mM imidazole and bound proteins were eluted by washing with 500 mM imidazole. Eluted proteins were separated by SDS-PAGE and visualized by
Coomassie brilliant blue staining. Lane 1 shows the contents of the E. coli lysate employed in lane 5. Molecular mass markers (M) are shown to the left in
kilodaltons. E) Since HrpB2XAC and HrcUXAC_His277-357 are not easily separated by SDS-PAGE, the presence of both HrpB2XAC and HrcUXAC_His277-357 in the
bound fractionshown in lane 4 of Figure 2D was demonstrated by Western blot using polyclonal antisera raised against HrcUXAC_207-357AAAH (lane 1) and
against HrpB2XAC (lane 2). The masses of molecular weight markers (in kDa) are indicated to the left of parts A-E.
doi:10.1371/journal.pone.0017614.g002
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importance of the FQALM motif we mutated these residues to
LQGPR and expressed the mutant protein (HrpB2XAC_LQGPR)i n
the DhrpB2 strain using the pUFR047_hrpB2LQGPR plasmid. The
DhrpB2+pUFR047_hrpB2LQGPR strain was able to cause citrus
canker symptoms in a manner indistinguishable from the wild-
type Xac strain (Fig. 4B). Therefore, the FQALM motif does not
seem to be essential for HrpB2 function. When the DhrpB2
strain was transformed with plasmids pUFR047_hrpB21-56 and
pUFR047_hrpB21-123, leading to the expression of HrpB2XAC_1-56
and HrpB2XAC_1-123 respectively, neither of the resulting strains
were able to induce citrus canker symptoms in orange leaves
(Fig. 4C). These results suggested that the C-terminal region of
HrpB2XAC which contains the conserved TLMKNQ motif is
important for HrpB2 function. To test the importance of each
residue in this motif, six hrpB2XAC mutants in which each of these
residues were changed to alanine were expressed the DhrpB2
strain. The results showed while the Xac strain expressing
HrpB2XAC_T125A was not able produce canker symptoms,
the strains expressing HrpB2XAC_V127A, HrpB2XAC_K128A,
HrpB2XAC_N129A and HrpB2XAC_Q130A produced canker symp-
toms to the same extent as wild-type Xac. Furthermore, DhrpB2
cells expressing HrpB2XAC_L126A produced attenuated citrus canker
symptoms when compared to the same cells containing the
plasmid that expresses wild-type HrpB2XAC (Fig. 4D). These
results point to the importance of the TLMKNQ motif, and
especially to the first residue of this motif (T125), in the role of
HrpB2XAC in the development disease in citrus plants.
HrpB2XAC is secreted by Xac in liquid media
Rossier et al. [20], showed that in Xcv HrpB2 is secreted in a
T3SS-dependent manner. In that study, a mutant Xcv strain with
constitutive expression of the hrp locus (due to a constitutively
activated HrpG mutation) was used. No such mutant Xac strain
has yet been isolated or produced. Expression of hrp genes in Xcv is
dependent on unknown plant signals and is controlled by specific
promoters with PIP boxes [33,34,35]. In Ralstonia solanacearum, hrp
expression is dependent on contact with an unidentified
component derived from the host cell wall [36,37,38] and passion
fruit leaf extracts have been shown to modify the proteome of X.
axonopodis pv. passiflorae [39]. We therefore grew liquid Xac
cultures in the presence of extracts derived from sweet orange (C.
sinensis) leaves. Proteins in the secreted fraction were separated by
SDS-PAGE and probed for HrpB2XAC by Western blot analysis
using anti-HrpB2XAC antiserum. We found that HrpB2XAC could
be observed in the secreted fraction of wild-type cells (Fig. 6A, lane
1). As expected, secretion of HrpB2XAC was abolished in the
DhrpB2 mutants and complementation with pUFR047_hrpB2
restored HrpB2XAC secretion (Fig. 6A, lanes 2 and 3, respectively).
We did not detect HrpB2XAC in the cellular fractions (data not
shown) but note that the secreted fraction was concentrated 60-
fold in relation to the cellular fraction (see Experimental
Procedures).
We then asked whether the HrpB2XAC mutants described above
were secreted when expressed in the DhrpB2 strain. Figure 6A
(lanes 4, 5 and 6) shows that HrpB21-56 (5.7 kDa), HrpB21-123
(13 kDa) and HrpB2XAC_LQGPR were all observed in Xac culture
supernatants. Furthermore, all six mutants carrying alanines at
each position of the TLMKNQ motif could be detected in Xac
culture supernatants (Fig. 6B, lanes 2 and 3 and data not shown).
Finally, we observed that HrpB2XAC secretion was abolished in
the DhrcU mutant (Fig. 6C, lane 2). Complementation of the DhrcU
mutant with pUFR047_hrcU restored HrpB2XAC secretion to wild-
type levels (Fig. 6C, lane 3). Interestingly, complementation of the
DhrcU mutant with pUFR047_hrcUAAAH resulted in significantly
reduced levels of HrpB2XAC secretion (Fig. 6, lane 4). This
difference in levels of HrpB2XAC secretion may, therefore, be due
to the inability of the HrcUXAC_AAAH protein to undergo the self-
cleavage reaction. Apparently, only minimal amounts of
HrpB2XAC are necessary to elicit citrus canker symptoms during
the infection process.
Figure 3. HrpB2XAC induced changes in HrcUXAC fluorescence.
Fluorescence emission spectra of HrcUXAC_207-264 (A), HrcUXAC_207-357AAAH
(B) and HrcUXAC_His277-357 (C) in the absence (dotted lines) and presence
(solid lines) of HrpB2. All proteins (2 mM) were dissolved in 5 mM sodium
acetate (pH 6.0). Spectra were recorded at 25uC using an excitation
wavelength of 280 nm.
doi:10.1371/journal.pone.0017614.g003
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In order to determine whether HrcUXAC and its NPTH site
were necessary for Xac survival in inoculated host leafs, we
inoculated Citrus leafs with Xac bacterial suspensions and
accompanied bacterial numbers during a 12 day period after
infection. Figure 7A shows that wild-type Xac, DhrcU, DhrcU+
pUFR047_hrcU, DhrcU+pUFR047_hrcUAAAH strains all presented
similar growth curves. This suggests that HrcUXAC is not
absolutely required for bacterial survival in planta, in spite of the
fact that the DhrcU does not produce canker disease symptoms. In
contrast, the DhrpB2 strain presented significantly reduced survival
when compared to the wild-type and DhrpB2+pUFR047_hrpB2
strains (Fig. 7B).
Discussion
In this study we constructed non-polar knock-out mutants for
the hrcU and hrpB2 genes and show that they completely abolish
pathogenicity of Xac in sweet orange. Complementation of the
DhrcU strain with plasmids pUFR047_hrcU or pUFR047_hrcUAAAH
recovered the capacity to induce disease symptoms. We also
demonstrated that HrpB2XAC is secreted to the extracellular space
Table 1. Strains used in this study.
Strains Relevant characteristics Source
Bacterial Strains:
E. coli DH10B Recipient for cloning experiments [56]
E. coli BL21(DE3) IPTG-inducible T7 RNA polymerase [58]
E. coli BL21(DE3) (RIL) IPTG-inducible T7 RNA polymerase [59]
Xac strain 306 Template for PCR-based cloning [7]
Xac DhrcU Xac strain carrying deletion of hrcU gene (codons 14–347) This study
Xac DhrpB2 Xac strain carrying deletion of hrpB2 gene (codons 10–119) This study
Xac DhrcU+pUFR047 _hrcU Xac DhrcU carrying pUFR047_hrcU This study
Xac DhrcU+pUFR047_hrcUAAAH Xac DhrcU carrying pUFR047_hrcUAAAH This study
Xac DhrpB2+pUFR047_hrpB2 Xac DhrpB2 carrying pUFR047_hrpB2 This study
Xac DhrpB2+pUFR047_hrpB21-56 Xac DhrpB2 carrying pUFR047_hrpB21-56 This study
Xac DhrpB2+pUFR047_hrpB21-123 Xac DhrpB2 carrying pUFR047_hrpB21-123 This study
Xac DhrpB2+pUFR047_hrpB2LQGPR Xac DhrpB2 carrying pUFR047_hrpB2LQGPR This study
Xac DhrpB2+pUFR047_hrpB2T125A Xac DhrpB2 carrying pUFR047_hrpB2T125A This study
Xac DhrpB2+pUFR047_hrpB2L126A Xac DhrpB2 carrying pUFR047_hrpB2L126A This study
Xac DhrpB2+pUFR047_hrpB2V127A Xac DhrpB2 carrying pUFR047_hrpB2V127A This study
Xac DhrpB2+pUFR047_hrpB2K128A Xac DhrpB2 carrying pUFR047_hrpB2K128A This study
Xac DhrpB2+pUFR047_hrpB2N129A Xac DhrpB2 carrying pUFR047_hrpB2N129A This study
Xac DhrpB2+pUFR047_hrpB2Q130A Xac DhrpB2 carrying pUFR047_hrpB2Q130A This study
Strains Relevant characteristics Source
Bacterial Strains:
E. coli DH10B Recipient for cloning experiments [56]
E. coli BL21(DE3) IPTG-inducible T7 RNA polymerase [58]
E. coli BL21(DE3) (RIL) IPTG-inducible T7 RNA polymerase [59]
Xac strain 306 Template for PCR-based cloning [7]
Xac DhrcU Xac strain carrying deletion of hrcU gene (codons 14–347) This study
Xac DhrpB2 Xac strain carrying deletion of hrpB2 gene (codons 10–119) This study
Xac DhrcU+pUFR047 _hrcU Xac DhrcU carrying pUFR047_hrcU This study
Xac DhrcU+pUFR047_hrcUAAAH Xac DhrcU carrying pUFR047_hrcUAAAH This study
Xac DhrpB2+pUFR047_hrpB2 Xac DhrpB2 carrying pUFR047_hrpB2 This study
Xac DhrpB2+pUFR047_hrpB21-56 Xac DhrpB2 carrying pUFR047_hrpB21-56 This study
Xac DhrpB2+pUFR047_hrpB21-123 Xac DhrpB2 carrying pUFR047_hrpB21-123 This study
Xac DhrpB2+pUFR047_hrpB2LQGPR Xac DhrpB2 carrying pUFR047_hrpB2LQGPR This study
Xac DhrpB2+pUFR047_hrpB2T125A Xac DhrpB2 carrying pUFR047_hrpB2T125A This study
Xac DhrpB2+pUFR047_hrpB2L126A Xac DhrpB2 carrying pUFR047_hrpB2L126A This study
Xac DhrpB2+pUFR047_hrpB2V127A Xac DhrpB2 carrying pUFR047_hrpB2V127A This study
Xac DhrpB2+pUFR047_hrpB2K128A Xac DhrpB2 carrying pUFR047_hrpB2K128A This study
*See Table 2 for plasmid construction details.
doi:10.1371/journal.pone.0017614.t001
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secretion was abolished in the DhrcU knockout and restored in the
DhrcU+pUFR047_hrcU and DhrcU+pUFR047_hrcUAAAH strains,
but the amount of HrpB2XAC secreted by the DhrcU+
pUFR047_hrcUAAAH strain was reduced with respect to that
observed for the wild-type and DhrcU+pUFR047_hrcU strains
(Figure 6C). This result suggests that while HrcUXAC cleavage
may not be absolutely necessary for the proper functioning of the
Xac T3SS, it may contribute to the efficiency by which it carries
out its tasks.
In this report we have shown that HrcUXAC expressed in E. coli
suffers proteolysis at a highly conserved NPTH site in a manner
similar to that already described for its paralog FlhB of the flagellar
system [24] and its orthologs YscU, EscU and SpaS from the
T3SSs of Yersina [26,40], E. coli and Salmonella [30] respectively.
This, and a similar report for the HrcU protein from Xanthomonas
campestris pv. vesicatoria [21], are the first observations of NPTH-
dependent cleavage of a FlhB homolog from the T3SS of a plant
pathogen. Ferris et al. [25] have shown that FlhB cleavage at the
NPTH site is an autocatalytic process; that is, FlhB catalyzes its
own hydrolysis at this site. Furthermore, a series of crystal
structures of the C-terminal domains of the FlhB homologs EscU
and SpaS from the E. coli and Salmonella T3SSs [30], and YscU
from Yersinia enterocolitica [29] have recently provided information
regarding the mechanism and conformational changes associated
with self-cleavage.
We also show that the HrcUXAC C-terminal fragment that is
released upon HrcUXAC self-cleavage interacts with HrpB2XAC,
whose only known homologs are found in the phytopathogens
Xanthomonas spp., Ralstonia solanacearum, and Acidovorax avenae, as well
as Burkholderia spp that infect both animals and plants. Our results
show that HrpB2XAC does not interact specifically with the site of
HrcUXAC cleavage since it could bind to HrcUXAC_207-357(AAAH)
and to HrcUHis277-357, a fragment that begins 10 residues after the
NPTH site. Unfortunately we were not able to detect HrcUXAC in
the wild-type or complemented mutant strains using the anti-
HrcUXAC polyclonal antibodies in this study (data not shown) and
so could not determine relative levels of HrcUXAC in the Xac
strains nor have we so far been able to determine whether
HrcUXAC is in fact cleaved at the NPTH site in Xac cells.
However, during the preparation of this work, HrcU cleavage was
observed in Xcv [21].
In order to understand HrcU function it is useful to recall
what we know about the functioning of HrcU homologs.
Table 2. Plasmids used in this study.
Plasmids Relevant characteristics Source
pET-11d T7 RNA polymerase - based expression vector [57]
pET-3a T7 RNA polymerase - based expression vector [57]
pET-28a (+) T7 RNA polymerase - based expression vector Novagen
pU1 pET-11d based vector expressing HrcUXAC_207-357 This study
pU2 pET-11d based vector expressing HrcUXAC_207-357(AAAH) This study
pU3 pET-28a(+) based vector expressing HrcUXAC_His277-357 This study
pB2 pET-3a based vector expressing HrpB2XAC This study
pET-Tmy143-284 pET-3a based vector expressing chicken alpha tropomyosin [60]
pNPTS138 Suicide vector, Km
r/SacB Dickon Alley*
pUFR047 Wide host range vector, Gm
r [63]
pBBR1MCS-5 Wide host range vector, Gm
r [62]
pNPTS138_DhrcU Suicide vector carrying internal truncation of Xac hrcU gene This study
pNPTS138_DhrpB2 Suicide vector carrying internal truncation of Xac hrpB2 gene This study
pBBR_hrcU pBBR1MCS-5 vector carrying Xac hrcU gene This study
pBBR_hrcUAAAH pBBR1MCS-5 vector carrying Xac hrcU gene with mutations that change NPTH motif to AAAH This study
pUFR047_hrcU pUFR047 based vector for expression of HrcUXAC in Xac This study
pUFR047_hrcUAAAH pUFR047 based vector for expression of HrcUXAC_AAAH in Xac This study
pBBR_hrpB2 pBBR1MCS-5 vector carrying Xac hrpB2 gene This study
pUFR047_hrpB2 pUFR047 based vector for expression of HrpB2XAC in Xac This study
pUFR047_hrpB21-56 pUFR047 based vector for expression of HrpB2XAC_1-56 in Xac This study
pUFR047_hrpB21-123 pUFR047 based vector for expression of HrpB2XAC_1-123 in Xac This study
pUFR047_hrpB2LQGPR pUFR047 based vector for expression of HrpB2XAC_LQGPR in Xac This study
pUFR047_hrpB2T125A pUFR047 based vector for expression of HrpB2XAC_T125A in Xac This study
pUFR047_hrpB2L126A pUFR047 based vector for expression of HrpB2XAC_L126A in Xac This study
pUFR047_hrpB2V127A pUFR047 based vector for expression of HrpB2XAC_V127A in Xac This study
pUFR047_hrpB2K128A pUFR047 based vector for expression of HrpB2XAC_K128A in Xac This study
pUFR047_hrpB2N129A pUFR047 based vector for expression of HrpB2XAC_N129A in Xac This study
pUFR047_hrpB2Q306A pUFR047 based vector for expression of HrpB2XAC_Q130A in Xac This study
*unpublished.
doi:10.1371/journal.pone.0017614.t002
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homologs exhibit defects in the secretion of specific substrates.
For example, in FlhB, mutations at this site inhibit the export of
‘‘late’’ flagellar proteins, while normal levels of early substrates,
including hook protein FlgE, are secreted [27]. Also, a Y.
enterocolitica DyscU strain expressing YscUN263A, in which the
conserved Asn residue of the NPTH sequence was mutated to
Ala, produced longer needles, exported reduced amounts of
YscP (a FliK homolog, see below) and did not export the
translocator proteins LcrV, YopB and YopD. The first two
defects could be compensated by overexpression of YscP (see
below) while export of LcrV, YopB and YopD was absolutely
dependent on a cleavable NPTH site [28].
The cleaved FlhB C-terminal fragment binds to both early and
late flagellar export substrates (FlgD, FliC). Furthermore, the
product of the fliK gene, FliK or flagellar hook-length control
protein, binds to the self-cleavage C-terminal fragment of FlhB
[24] and during flagellar assembly FliK is itself secreted
subsequent to hook protein subunit secretion [41,42]. Also, fliK
mutants do not secrete late substrates but do secrete excessive
amounts of hook protein (FlgE), resulting in the production of
characteristic polyhooks [43]. This phenotype can be reverted by
single amino acid substitutions in FlhB, almost all of which map to
the C-terminal self-cleavage fragment [27,43,44,45]. Thus, in the
flagellar system, FlhB and FliK act together to control substrate
switching from early to late substrates, though the molecular
mechanism by which this is achieved is not fully understood
[41,46].
In the animal pathogens Yersinia, Salmonella and Shigella, the
formation of needle complexes and subsequent secretion of
virulence factors by T3SSs are controlled by an interplay between
FlhB and FliK homologs. In these systems, mutations in the FliK
homologs YscP [47,48], InvJ [49] or Spa32 [50] result in the
formation of needles of variable length and compromised
virulence factor secretion. In the case of Yersinia, the phenotypes
can be reverted by mutations in the cytosolic domains of the FlhB
homolog YscU [47]. Futhermore, YscP, InvJ and Spa32 are
secreted during T3SS assembly [50,51,52] in a manner similar to
the secretion of FliK in the flagellar system. Finally, in Yersinia,
YscP secretion appears to be coupled to the secretion of another
small protein (YscO) that binds preferentially to the uncleaved
form of YscU [53].
Figure 4. HrcU and HrpB2 contribute to Xac pathogenicity during infection of Citrus sinensis. Macroscopic symptoms 15 days after
inoculation on the abaxial surface of leafs with DhrcU (A) and DhrpB2 (B-D) mutants. The following strains were used: Xac wild-type (WT), DhrcU,
DhrcU+pUFR047_hrcU (DhrcU+hrcU), DhrcU+pUFR047_hrcUAAAH (DhrcU+hrcUAAAH), DhrpB2, DhrpB2+pUFR047_hrpB2 (DhrpB2+hrpB2),
DhrpB2+pUFR047_hrpB21-56 (DhrpB2+hrpB21-56), DhrpB2+pUFR047_hrpB21-123 (DhrpB2+hrpB21-123), DhrpB2+pUFR047_hrpB2LQGPR (DhrpB2+hrpB2LQGPR),
DhrpB2+pUFR047_hrpB2T125A (DhrpB2+hrpB2T125A), DhrpB2+pUFR047_hrpB2L126A (DhrpB2+hrpB2L126A), DhrpB2+pUFR047_hrpB2V127A
(DhrpB2+hrpB2V127A), DhrpB2+pUFR047_hrpB2K128A (DhrpB2+hrpB2K128A), DhrpB2+pUFR047_hrpB2N129A (DhrpB2+hrpB2N129A)a n d
DhrpB2+pUFR047_hrpB2L130A (DhrpB2+hrpB2L130A).
doi:10.1371/journal.pone.0017614.g004
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identified in plant-associated bacteria: HrpP from Pseudomonas
syringae, RspP from P. fluorescens, HpaP from R. solanacearum [54]
and the HpaP/HpaC proteins coded by the hrp gene clusters of
Xanthomonas spp (for example HpaC in Xcv and HpaP in Xac).
During the preparation of this work Lorenz et al. [21] published a
study on the HpaC and HrpB2 proteins from Xcv. They found
that: 1) amino acids 10 to 25 of HrpB2 are crucial for its efficient
secretion and function and that HrpB2 is necessary for the
secretion of effectors and of extracellular components of the
secretion apparatus, 2) HrpB2 and HpaC interact with each other
and both also interact with the C-terminal domain of HrcU and 3)
HrpB2 secretion is suppressed by HpaC. They therefore
speculated that HpaC acts to control the switch between the
secretion of early to late T3SS substrates (see also reference [20])
and that HpaC binding to HrcU specifically inhibits HrpB2
binding and secretion [21]. While HpaC from Xcv has been shown
to be necessary for the secretion of both T3SS effector and
translocon proteins, it is not required for the export of the Hrp
pilus protein HrpE [55]. In this sense, the hpaC mutant phenotype
in Xcv is similar to that observed for yscP, invJ and spa32 mutants
(see above). However, HpaC itself is not secreted by Xcv and Hrp
pilus formation was not affected in hpaC mutant strains (different
from that observed for yscP, invJ and spa32 mutants as described
above) [55]. On the other hand, HrpB2 binds to HrcU and, like
FliK and YscP, HrpB2 is itself secreted. Since both HrpB2 and
HpaC bind to the C-terminal domain of HrcU, the accumulated
evidence so far is not clear as to which (if either) HpaC-HrcU or
HrpB2-HrcU complexes carry out molecular functions in the
Figure 5. Graphical Representation of the multiple sequence alignment of the HrpB2 protein family. The Pfam database [64] lists 61
sequences in this group (PF09487) from Xanthomonas (13 sequences), Burkholderia (43 sequences), Ralstonia (3 sequences), and Acidovorax (2
sequences) species. However, after removal of all sequences with greater that 95% identity, only 16 remain. These 16 sequences were used to
generate this representation using the WebLogo server (http://weblogo.berkeley.edu/) [65] in which the height of the residue symbol indicates the
degree of conservation (the representation obtained using all 61 sequences is highly similar). Numbers refer to residue positions in HrpB2XAC. The
FQALM and TLMKNQ motifs are underlined.
doi:10.1371/journal.pone.0017614.g005
Figure 6. HrpB2XAC is secreted by Xac. Liquid cultures of Xac were
grown as described in Materials and Methods. Secreted fractions were
concentrated and separated by SDS-PAGE 18% and proteins were tran-
sferred to nitrocellulose membranes. HrpB2XAC was detected using anti-
HrpB2XAC antiserum and revealed using anti-mouse IgG conjugated with
horseradish peroxidase. (A)L a n e1 :Xac wild-type, lane 2: Xac DhrpB2,lane
3: Xac DhrpB2+pUFR047_hrpB2,l a n e4 :Xac DhrpB2+pUFR047_hrpB21-56,
lane 5: Xac DhrpB2+pUFR047_hrpB21-123,l a n e6 :Xac DhrpB2+pUFR047_
hrpB2LQGPR.( B)L a n e1 :Xac wild-type, lane 2: Xac DhrpB2+pUFR047_
hrpB2T125A,l a n e3 :Xac DhrpB2+pUFR047_hrpB2Q130A, lane 4: Xac DhrpB2.
(C)L a n e1 :Xac wild-type, lane 2: Xac DhrcU,l a n e3 :Xac DhrcU+pUFR047_
hrcU and lane 4: Xac DhrcU+pUFR047_hrcUAAAH.
doi:10.1371/journal.pone.0017614.g006
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FlhB-FliK described above.
One interesting observation from our study was that while both
DhrcU and DhrpB2 knockout strains do not induce citrus canker
symptoms, only the latter presents a significant reduction in
survival in the host tissue. The DhrcU mutant survives as well as the
wild type strain in the host tissue, but does not detectably secrete
HrpB2. A similar phenomena has been observed in X. campestris
pv. glycines 8ra where HrcU is required for pathogenicity in its
natural soybean host but is not required for multiplication in the
host plant nor is it required for the induction of HR in non-hosts
[22]. The molecular basis for the differences in the DhrcU and
DhrpB2 phenotypes in Xac is not yet clear. One possibility is that
the DhrcU mutant fails to secrete effector(s) that trigger specific
host defense mechanisms resulting in the bacterial survival.
Another possibility is that intracellular HrpB2 may contribute to
Xac survival while extracelular HrpB2 contributes to citrus canker
symptom development.
In Xcv, deletion of HrpB2 residues 10-25 impaired protein
secretion and disease symptom formation, which led to the
conclusion that secretion is required for function [21]. We
demonstrated that while DhrpB2+pUFR047_hrpB21-56, DhrpB2+
pUFR047_hrpB21-123 and DhrpB2+pUFR047_hrpB2T125A strains
are not able to cause citrus canker, the truncated HrpB2XAC
polypeptides and HrpB2XAC single amino acid substitution
mutants are all however secreted to the extracellular space.
Therefore, HrpB2XAC secretion, per se, is not sufficient for
HrpB2XAC function. Apparently, the conserved C-terminal region
of the protein, more specifically residue T125 in the conserved
TLMKNQ motif, is especially important for HrpB2XAC-depen-
dent pathogenicity.
Important unanswered questions remain regarding HrpB2
function at the molecular level. Further studies are needed to
determine whether HrpB2 exercises a role in substrate switching
or as a minor structural component of the T3SS pilus (as do hook-
filament junction and capping proteins in bacterial flagella) or
carries out other, as yet not contemplated, functions and also
whether these functions are effected within the bacterial cell or in
the exterior subsequent to its secretion (or both).
Materials and Methods
Construction vectors for the expression of
HrcUXAC_207-357, HrcUXAC_His277-357, HrcUXAC_207-357(AAAH)
and HrpB2XAC in E. coli
E. coli strains and plasmids are described in Table 1 and
Table 2, respectively. E. coli cells were cultivated at 37uCi n2 x Y T
media [56]. When necessary, the appropriate antibiotics were
added at the following final concentrations: ampicillin 200 mg/
ml, kanamycin 50 mg/ml and chloramphenicol 200 mg/ml.
Synthetic oligonucleotide primers (Table 3) for polymerase chain
reactions (PCR) were designed containing restriction sites useful
for cloning (see below). PCR products were purified from agarose
gels using the QIAquick Gel Extraction Kit (Qiagen). To produce
a vector for the expression of HrcUXAC_207-357, the DNA
sequence coding residues 207-357 of the hrcU gene was amplified
from genomic Xac DNA using the oligonucleotides F-U207-357 and
R-U207-357 (Table 3). The PCR product was digested with
endonucleases NcoI and HindIII and inserted into the expression
vector pET-11d [57], previously digested with the same enzymes
to produce plasmid pU1. Primers F-UAAAH and R-UAAAH
(Table 3) were used in PCR with pU1 as template in order to
change the codons for residues 264-266 to alanine codons using
the QuikChange Site-Directed Mutageneis Kit (Stratagene).
The resulting recombinant plasmid (pU2) directs the expression
of HrcUXAC_207-357(AAAH). Note that in both recombinant
HrcUXAC_207-357 (through which HrcUXAC_207-264 is purified,
see below) and HrcUXAC_207-357(AAAH), residues Gln207 and
His208 have been mutated to Met and Asp residues, respec-
tively, due to the introduction of restriction sites used in the
cloning protocol. To produce a vector for the expression of
HrcUXAC_His277-357, the sequence coding for HrcU residues 277-
357 was amplified using primers F-UHis277-357 and R-UHis277-357
(Table 3). This product was digested with NdeI and HindIII and
Figure 7. Number of colony-forming units (CFU) of Xac strains per cm
2 of leaf tissue during the first twelve days after inoculation.
The abaxial surface of young leaves was pricked by using insect pins whose tips were previously immersed in the bacterial suspension for Xac hrcU
mutant strains (A) or by infiltration into leaves with needleless syringes for Xac hrpB2 mutant strains (B). Discs of infected leaves were excised,
homogenized and cultured quantitatively by incubation on agar plates. The assays were performed in triplicate and error bars represent the standard
deviation of the data. Differences in the initial bacterial populations are due to differences in the inoculation protocols. (A) Xac wild-type (diamonds),
DhrcU (squares), DhrcU+pUFR047_hrcU (triangles), DhrcU+pUFR047_hrcUAAAH (crosses). (B) Xac wild-type (diamonds), DhrpB2 (squares),
DhrpB2+pUFR047_hrpB2 (triangles).
doi:10.1371/journal.pone.0017614.g007
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digested with the same enzymes to produce the recombinant
plasmid pU3. To produce a vector for the expression of full-
length HrpB2XAC, the expression vector pET-3a (Studier et al.,
1990) was digested with HindIII, filled in with the Klenow
fragment of E. coli DNA polymerase I and then digested with
NdeI. Primers F-B2 and R-B2 were used in a PCR with Xac
genomic DNA, the product was treated with Klenow fragment
and polynucleotide kinase to produce blunt ends, digested with
NdeI and then ligated into the pET-3a vector described above to
produce the recombinant plasmid pB2. The accession numbers
for the complete Xac genome sequence and the HrpB2XAC and
HrcUXAC protein sequences are NC_003919, NP_640763 and
NP_640761, respectively.
Expression and purification of recombinant HrpB2XAC
and HrcUXAC fragments
Plasmid constructs pU1, pU2, and pB2 were used to transform
E. coli strain BL21(DE3) [58] and pU3 was used to transform
BL21(DE3)RIL cells [59]. The synthesis of recombinant proteins
was induced by the addition of 0.4 mM isopropyl-b-D-thioga-
lactopyranoside when cultures grown at 37uC attained an optical
density of 0.8 at 600 nm. After three more hours of growth, cells
were collected by centrifugation at 4500 x g for 15 min at 4uC
and ressuspended in 20 ml/l of culture of 25 mM Tris-HCl
(pH 8.0) for HrcUXAC fragments, and 5 mM sodium acetate
(pH 6.0) for HrpB2XAC. Cells were lysed by passage through a
French pressure cell followed by centrifugation at 37000 x g for
Table 3. Oligonucleotides used in this study.
Oligonucleotides Sequence
F-U207-357 59 CATCCCATGGACTGGCTGTTCATCCGGGAC 39
R-U207-357 59 CCCAAGCTTCTCGAGGCTCGCACGCGATCTCCTAG 39
F-UAAAH 59 GTGATGGTGGTCGCCGCGGCCCATTACGCGGTGGCAC
R-UAAAH 59 GTGCCACCGCGTAATGGGCCGCGGCGACCACCATCAC 39
F-UHis277-357 59 TAAATTGCTCATATGGATGACTTCGGCCTA 39
R-UHis277-357 59 TAAATTGCTCCATGGATGACTTCGGCCTA 39
F-B2 59 CGGAATTCCATATGACGCTCATTCCTCCTGTC 39
R-B2 59 CCGCTCGAGCTATTGGTTCTTGACCAGTGTCTG 39
F1-U 59 TCGGGACTAAAGCTTGCATCAACT TGATCT 39
R1-U 59 GGAATTACCATATGCAGTTTCTTCTCGGTCGGCTTCTC 39
F2-U 59 GGAATTACCATATGCACAGCGACGGCGATGGAGCT 39
R2-U 59 TTTGAACTTGCTAGCTGATCGGTGCCGCTG 39
R-compU 59 ATTTTAAGCTTGTCGACCTAGCATGGCAGAGCTCC 39
F1-B2 59 CACTACAAGCTTAAGCAACCAGCAAGGGGA 39
R1-B2 59 GGAATTACCATATGAATCGCTTGGACAGGAGGAAT 39
F2-B2 59 GGAATTACCATATGAAGAACGCCGTGCAGACACTG 39
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production of a 7 kDa polypeptide, not 17 kDa expected from
the size of the protein coded by the gene fragment in the pU1
vector (see Results). This polypeptide was purified from the
soluble fraction of the bacterial lysate by Q-Sepharose (Amer-
sham Bioscience) anion-exchange chromatography (25 mM Tris-
HCl (pH 8.0), 14 mM b-mercaptoethanol) using a 0-300 mM
NaCl gradient, followed by Superdex G-75 (Amersham Biosci-
ence) size exclusion chromatography (25 mM Tris-HCl (pH 8.0),
100 mM NaCl, 14 mM b-mercaptoethanol). HrcUXAC_207-
357(AAAH) and HrpB2XAC recombinant proteins were recovered
from the insoluble fraction of the bacterial lysate by solubilizing
in 25 mM Tris-HCl (pH 8.0), 14 mM b-mercaptoethanol, 8 M
urea for HrcUXAC_207-357(AAAH) or 5 mM sodium acetate
(pH 6.0), 14 mM b-mercaptoethanol, 8 M urea for HrpB2XAC.
HrcUXAC_207-357(AAAH) was purified by Q-Sepharose anion-
exchange chromatography, using the solubilization buffer (above)
and a 0-300 mM NaCl gradient followed by Superdex G-75 size
exclusion chromatography using 25 mM Tris-HCl (pH 8.0),
100 mM NaCl, 14 mM b-mercaptoethanol, 8 M urea.
HrpB2XAC was purified by passing the protein mixture through
a Q-sepharose column equilibrated with 5 mM sodium acetate
(pH 6.0), 14 mM b-mercaptoethanol, 8 M urea. HrpB2XAC does
not bind to this column under these conditions. The unbound
fraction containing HrpB2XAC was concentrated using an 10 kDa
Amicon filter (Millipore) and separated by Superdex G-75 size
exclusion chromatography using 5 mM sodium acetate (pH 6.0),
100 mM NaCl, 14 mM b-mercaptoethanol, 8 M urea.
HrcUXAC_207-357(AAAH) and HrpB2XAC were refolded by dialyses
against 25 mM Tris-HCl (pH 8.0), 14 mM b-mercaptoethanol
for HrcUXAC_207-357(AAAH), or 5 mM sodium acetate (pH 6.0),
14 mM b-mercaptoethanol for HrpB2XAC containing successive-
ly reduced amounts of urea: 6 M, 4 M, 2 M, 0 M. HrcUHis277-357
was purified from the insoluble fraction of the bacterial lysate by
solubilizing in 25 mM Tris-HCl (pH 8.0), 10 mM imidazole,
100 mM NaCl, 2 mM b-mercaptoethanol, 8 M urea. The
protein mixture was applied to a Ni
2+-chelating Sepharose
column equilibrated with the same buffer and eluted using a
25-500 mM imidazole gradient. HrcUXAC_His277-357 fractions
were pooled and the protein was refolded by successive dialyses
against 25 mM Tris-HCl (pH 8.0), 14 mM b-mercaptoethanol
containing 6 M, 4 M, 2 M and 0 M urea.
Production of polyclonal antibodies against
HrcUXAC207-357(AAAH) and HrpB2XAC proteins
Swiss Webster mice were immunized with four injections,
separated by one week intervals, of 10 mg soluble HrpB2XAC. New
Zealand white rabbits were immunized with HrcUXAC_207-357(AAAH)
using four 200 mg injections separated byone week intervals. In both
cases, the antigens were diluted with one volume of complete
Freund’s adjuvant (Sigma) for the first immunization and one
volume of incomplete Freund’s adjuvant (Sigma) for the remaining
immunizations. Blood was collected and incubated for 1 hr at 37uC
and the serum was recovered by centrifugation at 5000 x g for
15 min at room temperature, aliquoted and stored at -20uC. Before
use, antiserum aliquots were incubated with an E. coli lysate as
described [56].
Edman degradation N-terminal sequencing
The N-terminus of the 7 kDa polypeptide purified after the
expression of HrcUXAC_207-357 was lyophilized and dissolved in
ultrapure water. N-terminal sequencing was carried out by Edman
degradation using a PPSQ/23 sequencer (Shimadzu Corporation,
Tokyo).
Mass spectrometry experiments
Purified proteins were analyzed by Matrix Assisted Laser
Desorption Ionization (MALDI) Time of Flight (TOF) Mass
Spectrometry (MS) using an Ettan MALDI-TOF Pro system
(Amersham Biosciences). All MALDI-TOF MS spectra were
externally calibrated using a cytochrome C standard (12327 Da).
Protein mass was identified in linear mode with positive ionization
at 20 kV. The samples were mixed with an equal volume of
sinapinic acid matrix dissolved in 50% acetonitrile, 0.5% of
trifluoroacetic acid. A 0.5 ml aliquot was loaded onto stainless steel
MALDI slides for analysis. Spectra were analyzed using the Ettan
Maldi-Tof Pro v2.0 software package.
Western blot assays
Samples were separated by SDS-PAGE (18% acrylamide) and
electroblotted onto a nitrocellulose membrane. The membrane
was colored with Ponceau red to identify the positions of specific
proteins and then blocked for 2 h with 10 mM Tris-HCl (pH 7.5),
150 mM NaCl, 0.1% Tween 20, 0.1% Triton (TBS-TT) and 5%
non-fat dry milk. The membranes were probed for 2 h with the
appropriate polyclonal antiserum in 5-10 ml of the above blocking
buffer (1:3000 dilution for anti-HrcUXAC antibody and 1:20000
dilution for the anti-HrpB2XAC antibody) and then washed four
times for 15 min with TBS-TT. The anti-HrpB2XAC antibody was
detected using an anti-mouse IgG conjugated with horseradish
peroxidase (Sigma) at a dilution of 1:6000. The anti-HrcUXAC
antibody was detected using protein A conjugated with horserad-
ish peroxidase (Sigma) at a dilution of 1:30000. The membranes
were incubated for 2 h with the protein-A or anti-IgG conjugates
in 5-10 ml of blocking buffer following by washing with TBS-TT.
Reactive bands were detected using the ECL AdvanceTM
Western Blotting Detection Kit (GE Heathcare-Amersham)
according to the manufacturer’s instructions.
Far-Western assays
Far-Western blot assays were carried out to detect specific
protein-protein interactions. Approximately 15 mg of purified
recombinant protein or lysates from E. coli cells was separated
by SDS-PAGE (18% acrylamide) and electroblotted onto
nitrocellulose membranes. The membrane was blocked for 2 h
with TBS-TT plus 5% nonfat dry milk followed by 14 h
incubation with 50 mg/ml of a second purified recombinant
protein (indicated in the figure legends) at 4uC. Unbound proteins
were removed by washing the membranes four times for 15 min
with TBS-TT. Bound proteins were then detected as described for
the Western blot assays (above). In some cases, negative control
experiments were performed using a polypeptide derived from
residues 143-284 of chicken muscle a-tropomyosin [60].
His-tag pulldown assays
HrcUXAC_His277-357, HrpB2XAC and an E. coli lysate were
dialyzed at 4uC against 25 mM Tris-HCl, 100 mM NaCl, 2 mM
b-mercaptoethanol, 10 mM imidazole (pH 8.0). A mixture of
HrcUHis277-357 (30 mM) and HrpB2 (30 mM) was added to a 0.25-
ml aliquot of Ni
2+-chelating Sepharose resin (Amersham Biosci-
ence) equilibrated in the above buffer at room temperature.
In control experiments, the resin was mixed with only
HrcUXAC_His277-357 or HrpB2 or with a mixture of HrcUHis277-357
and a lysate derived from 10 ml of E. coli BL21(DE3) culture
(OD600=0.8). The mixtures were washed four times with 1 ml of
25 mM Tris-HCl, 100 mM NaCl, 2 mM 2-b-mercaptoethanol,
25 mM imidazole (pH 8.0). Bound proteins were released by
washing with 50 ml of 25 mM Tris-HCl, 100 mM NaCl, 2 mM 2-
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analyzed by SDS-PAGE and Western blot assay.
Fluorescence experiments
HrcUXAC_207-357(AAAH) and HrpB2XAC (both 2 mM) were
dissolved in 5 mM sodium acetate pH 6.0 at 25uC. Fluorescence
emission spectra were obtained using an AVIV (Lakewood, NJ)
ATF 105 Automated Titrating Differential/Ratio spectrofluorom-
eter and were collected between 320 and 400 nm using an
excitation wavelength of 280 nm and excitation and emission
bandwidths of 2 nm and 5 nm respectively.
Production of Xac genes knockouts
Deletion strains were constructed using the suicide vector
pNPTS138 (Alley Dickon, unpublished) by allelic exchange as
described [61]. DNA fragments (1 kb) flanking each side of the Xac
hrpB2 and hrcU genes were amplified by PCR using oligonucleotides
listed in Table 3. For hrcU, primer pairs F1-U + R1-U and F2-U +
R2-Uwere used. For hrpB2, primer pairs F1-B2 + R1-B2 and F2-B2
+ R2-B2 were used. The products were digested with endonuclease
NdeI and specific pairs were joined together with T4 DNA ligase
(New England Biolabs). The resulting fragments were cloned into
pNPTS138 generating pNPTS138-DhrcU using HindIII and NheI
and pNPTS138-DhrpB2 by using HindIII and SalI. These plasmids
were introduced by electroporation into Xac strain 306. Kanamycin
and ampicillin-resistant colonies were selected and grown on plates
containing 5% sucrose and ampicillin. Sucrose-sensitive and
kanamycin- and ampicilin-resistant colonies were selected and used
to inoculate 10 ml of 2xYT-ampicilin medium, which was
incubated overnight with agitation at 28uC. A 100 ml aliquot of
this culture was plated without dilution on 2xYT agar plates
containing 200mg/L ampicillin. The resulting colonies were
transferred in replica on two plates: one containing kanamycin
and ampicillin and another containing sucrose and ampicilin.
Clones that were simultaneously kanamycin-sensitive and sucrose-
resistant were selected, and the deletion was confirmed by PCR.
Production of expression vectors for complementation of
DhrcU and DhrpB2 in Xac
A fragment containing the hrcU gene plus 1 kb upstream
sequences was amplified by PCR using primers F1-U and R-
compU (Table 3). This fragment contains the complete HrcU
open reading frame as well as its native promoter. After digestion
with HindIII and SalI, this fragment was cloned into the HindIII-
SalI sites of pBBR1MCS-5 [62], resulting in pBBR_hrcU (Table 2).
To construct pBBR_hrcUAAAH (Table 2), primers F-UAAAH and R-
UAAAH (see Table 3) were used in a PCR amplification with
pBBR_hrcU as template to change the codons for residues 264-266
(NPT) to alanine codons using the QuikChange Site-Directed
Mutagenesis Kit (Stratagene). The mutation was confirmed by
sequencing. The HindIII/SalI fragments of pBBR_hrcU and
pBBR_hrcUAAAH, which contain the complete HrcUXAC open
reading frame as well as its native promoter, were cloned into the
same sites of pUFR047, a broad-host range vector carrying a
gentamycin resistance gene [63], generating constructs
pUFR047_hrcU and pUFR047_hrcUAAAH (Table 2). These plas-
mids were used to transform the DhrcU mutant strain by
electroporation followed by selection on LB plates with 10 mg/
ml gentamycin and 200 mg/ml ampicillin.
A fragment containing the hrpB2 gene plus 1 kb upstream
sequences was amplified by PCR using primers F1-B2 and R-
compB2 (Table 3), digested with HindIII and cloned into
the HindIII site of pUFR047. The resulting construct,
pUFR047_hrpB2 (Table 2) was used to transform the Xac DhrpB2
mutant strain by electroporation. Transformed colonies were
selected on LB/gentamycin/ampicilin plates to produce strain
DhrpB2+pUFR047_hrpB2 (Table 1). To produce hrpB2 gene
mutants for expression in Xac, the HindIII/SalI fragment of the
PCR product above was cloned between the HindIII and SalI sites
of pBBR1MCS-5 generating the construct pBBR_hrpB2 (Table 2)
which was then used as a template to produce mutants using the
QuikChange Site-Directed Mutagenesis Kit (Stratagene). Primers
F-M57 and R-M57, F-Q124 and R-Q124 (Table 3) were used to
change the codons 171 and 372 to stop codons; primers F-
FQALM and R-FQALM (Table 3) were used to change the
codons for the FQALM motif (residues 35-39) to LQGPR
codons and finally, primers pairs F-T125A and R-T125A,
F-L126A and R-L126A, F-V127A and R-V127A, F-K128A
and R-K128A, F-N129A and R-N129A and F-Q130A and R-
Q130A (Table 3) were used to change the respective codons to
alanine codons. The HindIII/SalI fragments from all these
pBBR_hrpB2 derived constructs were cloned between the same
sitesofpUFR047 generatingthe constructions pUFR047_hrpB21-56,
pUFR047_hrpB21-123, pUFR047_hrpB2T125A,p U F R 0 4 7 _hrpB2L126A,
pUFR047_hrpB2V127A, pUFR047_hrpB2K128A, pUFR047_hrpB2N129A,
and pUFR047_hrpB2Q130A (Table 2). All the mutations were
confirmed by sequencing. Theses constructions were used to
transform the Xac DhrpB2 strain by electroporation (Table 1).
Plant bioassays
Highly susceptible Navel sweet orange (Citrus sinensis (L.)
Osbeck) plants were grown under greenhouse conditions and
maintained at 28uC with daylight for virulence assays. To visually
monitor the development of citrus canker symptoms, Xac 306 and
mutant strains were grown overnight at 30uC and adjusted to an
optical density of 0.3 at 600 nm in 2xYT culture medium. The
suspensions were hand-infiltrated with a 1-ml syringe with needle
into the abaxial surface of attached leaves. To monitor bacterial
growth in planta, Xac strains were grown overnight at 30uC and
adjusted to an optical density at 600 nm (OD600) of 0.5 in NB
culture medium (8g of nutrient broth liter
-1, 5 g of NaCl liter
21,
pH 7). The abaxial surface of young leaves was pricked by using
pins whose tips were previously immersed in the bacterial
suspension for Xac hrcU mutant strains (Fig. 7A) or by infiltration
into leaves with needleless syringes for Xac hrpB2 mutant strains
(Fig. 7B). In both cases, leaf disks (0.8 cm
2) from infected plants
were removed with a cork borer during a 12 day period post-
inoculation, macerated in 0.85% NaCl with a mortar and pestle.
Different dilutions were spread on LB plates with the appropriate
antibiotics and the bacterial population was determined by
counting colonies after a 2-day incubation period at 28-30uC.
Experiments were performed in triplicate.
Preparation of orange leaf extracts
Sweet orange leaf extracts were prepared as described
previously for passion fruit leaf extracts [39]. Leaves were washed
extensively with sterile water. Midribs were excluded and 1 g of
tissue was mixed with liquid nitrogen and pulverized to form a fine
powder. One-hundred milliliters of MM medium [39] plus
carbenicillin 100 mg/ml, pH 7.4 were added and the mixture
was macerated followed by centrifugation at 5000 x g for 15 min
at 4uC. The supernatant was recovered and passed through
0.45 mm and 0.22 mm filters (Millipore) and stored at -80uC.
HrpB2 secretion by Xac
Xac 306 cells were cultivated at 30uC in MM medium (pH 5.4)
plus 100 mg/ml carbenicillin containing sweet orange leaf extract
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Xac cultures (50 mL) were grown for 24 h to an OD600=0.3 after
which cells were collected by centrifugation and resuspended in
3 ml of urea-SB: 8 M urea, 10% glycerol, 52 mM Tris-HCl
(pH 6.8), 2% SDS, 0.1% bromphenol blue, 140 mM 2-mercap-
toethanol. The extracellular (secreted) fraction from a 50 ml
culture was passed through a low protein-binding filter 0.45 mm
(Millipore). Proteins in the filtrates were precipitated by adding
10% trichloroacetic acid and freezing at 220uC for 12 h followed
by centrifugation at 12000 x g (4uC). The precipitate was washed
twice with cold acetone and resuspended in 50 ml urea-SB. Note
that the above procedure produces a secreted fraction that is
derived from 60 times as many bacterial cells per unit volume as
the cellular fraction. Equal volumes of cellular and secreted
protein fractions were separated by SDS-PAGE (18% acrylamide)
and transferred onto the nitrocellulose membrane. HrpB2 was
detected by Western blot using anti-HrpB2XAC antibodies (above).
Acknowledgments
We thank Fernando Corre ˆa for the help in the fluorescence measurements,
Izaura Nobuko Toma and Paolo di Mascio for MALDI-TOF MS analyses,
Izaura Yoshico Hirata for Edman degradation analyses, A ˆngela Mika
Katsuyama for the clone for expression of HrpB2, and Marcos C. Alegria
for helpful discussions.
Author Contributions
Conceived and designed the experiments: PAC AMA CSF. Performed the
experiments: PAC RFS AMA RAH TSS. Analyzed the data: PAC AMA
MAM CSF. Contributed reagents/materials/analysis tools: MAM CSF.
Wrote the paper: PAC CSF.
References
1. Blocker A, Komoriya K, Aizawa S (2003) Type III secretion systems and
bacterial flagella: insights into their function from structural similarities. Proc
Natl Acad Sci U S A 100: 3027–3030.
2. He SY, Nomura K, Whittam TS (2004) Type III protein secretion mechanism in
mammalian and plant pathogens. Biochim Biophys Acta 1694: 181–206.
3. Buttner D, He SY (2009) Type III protein secretion in plant pathogenic bacteria.
Plant Physiol 150: 1656–1664.
4. Rong W, Feng F, Zhou J, He C (2010) Effector-triggered innate immunity
contributes Arabidopsis resistance to Xanthomonas campestris. Mol Plant
Pathol 11: 783–793.
5. Alegria MC, Docena C, Khater L, Ramos CH, da Silva AC, et al. (2004) New
protein-protein interactions identified for the regulatory and structural
components and substrates of the type III Secretion system of the phytopathogen
Xanthomonas axonopodis Pathovar citri. J Bacteriol 186: 6186–6197.
6. Buttner D, Bonas U (2006) Who comes first? How plant pathogenic bacteria
orchestrate type III secretion. Curr Opin Microbiol 9: 193–200.
7. da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, et al. (2002)
Comparison of the genomes of two Xanthomonas pathogens with differing host
specificities. Nature 417: 459–463.
8. Kay S, Bonas U (2009) How Xanthomonas type III effectors manipulate the host
plant. Curr Opin Microbiol 12: 37–43.
9. Van Gijsegem F, Gough C, Zischek C, Niqueux E, Arlat M, et al. (1995) The
hrp gene locus of Pseudomonas solanacearum, which controls the production of
a type III secretion system, encodes eight proteins related to components of the
bacterial flagellar biogenesis complex. Mol Microbiol 15: 1095–1114.
10. Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, et al. (2009)
Identification of novel type III secretion effectors in Xanthomonas oryzae pv.
oryzae. Mol Plant Microbe Interact 22: 96–106.
11. Marguerettaz M, Pieretti I, Gayral P, Puig J, Brin C, et al. (2010) Genomic and
evolutionary features of the SPI-1 type III secretion system that is present in
Xanthomonas albilineans but is not essential for xylem colonization and
symptom development of sugarcane leaf scald. Mol Plant Microbe Interact 24:
246–259.
12. Szczesny R, Buttner D, Escolar L, Schulze S, Seiferth A, et al. (2010)
Suppression of the AvrBs1-specific hypersensitive response by the YopJ effector
homolog AvrBsT from Xanthomonas depends on a SNF1-related kinase. New
Phytol 187: 1058–1074.
13. Song C, Yang B (2010) Mutagenesis of 18 type III effectors reveals virulence
function of XopZ(PXO99) in Xanthomonas oryzae pv. oryzae. Mol Plant
Microbe Interact 23: 893–902.
14. Moreira LM, Almeida Jr. NF, Potnis N, Digiampietri LA, Adi SS, et al. (2010)
Novel insights into the genomic basis of citrus canker based on the genome
sequences of two strains of Xanthomonas fuscans subsp. aurantifolii. BMC Genomics
11: 238.
15. Pieretti I, Royer M, Barbe V, Carrere S, Koebnik R, et al. (2009) The complete
genome sequence of Xanthomonas albilineans provides new insights into the
reductive genome evolution of the xylem-limited Xanthomonadaceae. BMC
Genomics 10: 616.
16. Brunings AM, Gabriel DW (2003) Xanthomonas citri: breaking the surface. Mol
Plant Pathol 4: 141–157.
17. Dunger G, Arabolaza AL, Gottig N, Orellano EG, Ottado J (2005) Participation
of Xanthomonas axonopodis pv. citri hrp cluster in citrus canker and nonhost
plant responses. Plant Pathology 54: 8.
18. Swarup S, Yang Y, Kingsley MT, Gabriel DW (1992) An Xanthomonas citri
pathogenicity gene, pthA, pleiotropically encodes gratuitous avirulence on
nonhosts. Mol Plant Microbe Interact 5: 204–213.
19. Hiroshi S, Takashi F, Hiromichi I, Sinji T, Katsumi O (2007) A pthA homolog
from Xanthomonas axonopodis pv. citri responsible for host-specific suppression
of virulence. Journal of Bacteriology 189: 3271–3279.
20. Rossier O, Van den Ackerveken G, Bonas U (2000) HrpB2 and HrpF from
Xanthomonas are type III-secreted proteins and essential for pathogenicity and
recognition by the host plant. Mol Microbiol 38: 828–838.
21. Lorenz C, Schulz S, Wolsch T, Rossier O, Bonas U, et al. (2008) HpaC controls
substrate specificity of the Xanthomonas type III secretion system. PLoS Pathog
4: e1000094.
22. Oh C, Heu S, Yoo JY, Cho Y (1999) An hrcU-homologous gene mutant of
Xanthomonas campestris pv. glycines 8ra that lost pathogenicity on the host
plant but was able to elicit the hypersensitive response on nonhosts. Mol Plant
Microbe Interact 12: 633–639.
23. Bonas U, Shulte R, Fenselau S, Minsavage GV, Staskawicz BJ, et al. (1991)
Isolation of a gene cluster from Xanthomonas campestris pv. vesicatoria that
determines pathogenicity and the hypersensitive response on pepper and tomato.
Molecular Plant-Microbe Interactions 15: 109–119.
24. Minamino T, Macnab RM (2000) Domain structure of Salmonella FlhB, a
flagellar export component responsible for substrate specificity switching.
J Bacteriol 182: 4906–4914.
25. Ferris HU, Furukawa Y, Minamino T, Kroetz MB, Kihara M, et al. (2005) FlhB
regulates ordered export of flagellar components via autocleavage mechanism.
J Biol Chem 280: 41236–41242.
26. Lavander M, Sundberg L, Edqvist PJ, Lloyd SA, Wolf-Watz H, et al. (2002)
Proteolytic cleavage of the FlhB homologue YscU of Yersinia pseudotuberculosis
is essential for bacterial survival but not for type III secretion. J Bacteriol 184:
4500–4509.
27. Fraser GM, Hirano T, Ferris HU, Devgan LL, Kihara M, et al. (2003) Substrate
specificity of type III flagellar protein export in Salmonella is controlled by
subdomain interactions in FlhB. Mol Microbiol 48: 1043–1057.
28. Sorg I, Wagner S, Amstutz M, Muller SA, Broz P, et al. (2007) YscU recognizes
translocators as export substrates of the Yersinia injectisome. EMBO J 26:
3015–3024.
29. Wiesand U, Sorg I, Amstutz M, Wagner S, van den Heuvel J, et al. (2009)
Structure of the type III secretion recognition protein YscU from Yersinia
enterocolitica. J Mol Biol 385: 854–866.
30. Zarivach R, Deng W, Vuckovic M, Felise HB, Nguyen HV, et al. (2008)
Structural analysis of the essential self-cleaving type III secretion proteins EscU
and SpaS. Nature 453: 124–127.
31. Deane JE, Graham SC, Mitchell EP, Flot D, Johnson S, et al. (2008) Crystal
structure of Spa40, the specificity switch for the Shigella flexneri type III
secretion system. Mol Microbiol 69: 267–276.
32. Allaoui A, Woestyn S, Sluiters C, Cornelis GR (1994) YscU, a Yersinia
enterocolitica inner membrane protein involved in Yop secretion. J Bacteriol
176: 4534–4542.
33. Astua-Monge G, Freitas-Astua J, Bacocina G, Roncoletta J, Carvalho SA, et al.
(2005) Expression profiling of virulence and pathogenicity genes of Xanthomo-
nas axonopodis pv. citri. J Bacteriol 187: 1201–1205.
34. Fenselau S, Bonas U (1995) Sequence and expression analysis of the hrpB
pathogenicity operon of Xanthomonas campestris pv. vesicatoria which encodes
eight proteins with similarity to components of the Hrp, Ysc, Spa, and Fli
secretion systems. Mol Plant Microbe Interact 8: 845–854.
35. Koebnik R, Kruger A, Thieme F, Urban A, Bonas U (2006) Specific binding of
the Xanthomonas campestris pv. vesicatoria AraC-type transcriptional activator
HrpX to plant-inducible promoter boxes. J Bacteriol 188: 7652–7660.
36. Aldon D, Brito B, Boucher C, Genin S (2000) A bacterial sensor of plant cell
contact controls the transcriptional induction of Ralstonia solanacearum
pathogenicity genes. EMBO J 19: 2304–2314.
37. Brito B, Aldon D, Barberis P, Boucher C, Genin S (2002) A signal transfer
system through three compartments transduces the plant cell contact-dependent
signal controlling Ralstonia solanacearum hrp genes. Mol Plant Microbe
Interact 15: 109–119.
HrpB2 and HrcU Structure - Function Analysis
PLoS ONE | www.plosone.org 14 March 2011 | Volume 6 | Issue 3 | e1761438. Marenda M, Brito B, Callard D, Genin S, Barberis P, et al. (1998) PrhA controls
a novel regulatory pathway required for the specific induction of Ralstonia
solanacearum hrp genes in the presence of plant cells. Mol Microbiol 27:
437–453.
39. Tahara ST, Mehta A, Rosato YB (2003) Proteins induced by Xanthomonas
axonopodis pv. passiflorae with leaf extract of the host plant (Passiflorae edulis).
Proteomics 3: 95–102.
40. Riordan KE, Sorg JA, Berube BJ, Schneewind O (2008) Impassable YscP
substrates and their impact on the Yersinia enterocolitica type III secretion
pathway. J Bacteriol 190: 6204–6216.
41. Macnab RM (2003) How bacteria assemble flagella. Annu Rev Microbiol 57:
77–100.
42. Minamino T, Gonzalez-Pedrajo B, Yamaguchi K, Aizawa SI, Macnab RM
(1999) FliK, the protein responsible for flagellar hook length control in
Salmonella, is exported during hook assembly. Mol Microbiol 34: 295–304.
43. Williams AW, Yamaguchi S, Togashi F, Aizawa SI, Kawagishi I, et al. (1996)
Mutations in fliK and flhB affecting flagellar hook and filament assembly in
Salmonella typhimurium. J Bacteriol 178: 2960–2970.
44. Kutsukake K, Minamino T, Yokoseki T (1994) Isolation and characterization of
FliK-independent flagellation mutants from Salmonella typhimurium. J Bacteriol
176: 7625–7629.
45. Suzuki T, Iino T (1981) Role of the flaR gene in flagellar hook formation in
Salmonella spp. J Bacteriol 148: 973–979.
46. Macnab RM (1999) The bacterial flagellum: reversible rotary propellor and type
III export apparatus. J Bacteriol 181: 7149–7153.
47. Edqvist PJ, Olsson J, Lavander M, Sundberg L, Forsberg A, et al. (2003) YscP
and YscU regulate substrate specificity of the Yersinia type III secretion system.
J Bacteriol 185: 2259–2266.
48. Journet L, Agrain C, Broz P, Cornelis GR (2003) The needle length of bacterial
injectisomes is determined by a molecular ruler. Science 302: 1757–1760.
49. Kubori T, Sukhan A, Aizawa SI, Galan JE (2000) Molecular characterization
and assembly of the needle complex of the Salmonella typhimurium type III
protein secretion system. Proc Natl Acad Sci U S A 97: 10225–10230.
50. Tamano K, Katayama E, Toyotome T, Sasakawa C (2002) Shigella Spa32 is an
essential secretory protein for functional type III secretion machinery and
uniformity of its needle length. J Bacteriol 184: 1244–1252.
51. Collazo CM, Zierler MK, Galan JE (1995) Functional analysis of the Salmonella
typhimurium invasion genes invl and invJ and identification of a target of the
protein secretion apparatus encoded in the inv locus. Mol Microbiol 15: 25–38.
52. Payne PL, Straley SC (1999) YscP of Yersinia pestis is a secreted component of
the Yop secretion system. J Bacteriol 181: 2852–2862.
53. Riordan KE, Schneewind O (2008) YscU cleavage and the assembly of Yersinia
type III secretion machine complexes. Mol Microbiol 68: 1485–1501.
54. Agrain C, Callebaut I, Journet L, Sorg I, Paroz C, et al. (2005) Characterization
of a Type III secretion substrate specificity switch (T3S4) domain in YscP from
Yersinia enterocolitica. Mol Microbiol 56: 54–67.
55. Buttner D, Lorenz C, Weber E, Bonas U (2006) Targeting of two effector
protein classes to the type III secretion system by a HpaC- and HpaB-dependent
protein complex from Xanthomonas campestris pv. vesicatoria. Mol Microbiol
59: 513–527.
56. Sambrook J, Russel DW (2000) Molecular Cloning: A Laboratory Manual. New
York: Cold Spring Harbour Press.
57. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW (1990) Use of T7 RNA
polymerase to direct expression of cloned genes. Methods Enzymol 185: 60–89.
58. Studier FW, Moffatt BA (1986) Use of bacteriophage T7 RNA polymerase to
direct selective high-level expression of cloned genes. J Mol Biol 189: 113–130.
59. Kleber-Janke T, Becker WM (2000) Use of modified BL21(DE3) Escherichia coli
cells for high-level expression of recombinant peanut allergens affected by poor
codon usage. Protein Expr Purif 19: 419–424.
60. Paulucci AA, Hicks L, Machado A, Miranda MT, Kay CM, et al. (2002) Specific
sequences determine the stability and cooperativity of folding of the C-terminal
half of tropomyosin. J Biol Chem 277: 39574–39584.
61. Guzzo CR, Salinas RK, Andrade MO, Farah CS (2009) PILZ protein structure
and interactions with PILB and the FIMX EAL domain: implications for control
of type IV pilus biogenesis. J Mol Biol 393: 848–866.
62. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, et al. (1995) Four
new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying
different antibiotic-resistance cassettes. Gene 166: 175–176.
63. De Feyter R, Yang Y, Gabriel DW (1993) Gene-for-genes interactions between
cotton R genes and Xanthomonas campestris pv. malvacearum avr genes. Mol
Plant Microbe Interact 6: 225–237.
64. Finn RD, Mistry J, Tate J, Coggill P, Heger A, et al. (2010) The Pfam protein
families database. Nucleic Acids Res 38: D211–222.
65. Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence
logo generator. Genome Res 14: 1188–1190.
HrpB2 and HrcU Structure - Function Analysis
PLoS ONE | www.plosone.org 15 March 2011 | Volume 6 | Issue 3 | e17614